Invasive Aspergillosis associated with Covid-19: A word of caution.


Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 27 10 2020
revised: 02 12 2020
accepted: 28 12 2020
pubmed: 26 1 2021
medline: 24 6 2021
entrez: 25 1 2021
Statut: ppublish

Résumé

Invasive pulmonary aspergillosis is a well-known complication of acute respiratory distress syndrome, the most serious manifestation of COVID-19. Four recent studies have reported its incidence among ICU COVID-19 patients. However, they do not share the same case definition, and have provided conflicting results. In this paper we have aimed at reported the incidence of invasive pulmonary aspergillosis for COVID-19 patients in our ICU, and at comparing the different definitions in order to assess their respective relevance. Retrospective cohort study of critically ill patients with severe COVID-19 requiring ICU management between 1st March and 30th April 2020. Our results showed significantly lower incidence of invasive pulmonary aspergillosis (1.8%;1/53), compared to three out of four previous studies, and wide variation in the numbers of cases with regard to the different definitions. Large-scale studies are needed for a better definition and a more accurate estimation of invasive pulmonary aspergillosis coinfection during COVID-19.

Identifiants

pubmed: 33490993
doi: 10.1016/j.idnow.2020.12.008
pii: S2666-9919(20)00033-0
pmc: PMC7813486
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

383-386

Informations de copyright

© 2021 Elsevier Masson SAS. All rights reserved.

Références

JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Am J Respir Crit Care Med. 2012 Jul 1;186(1):56-64
pubmed: 22517788
Lancet Respir Med. 2020 Jun;8(6):e48-e49
pubmed: 32445626
Am J Respir Crit Care Med. 2020 Jul 1;202(1):132-135
pubmed: 32396381
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Intensive Care Med. 2020 Nov;46(11):2071-2074
pubmed: 32902729
Lancet Microbe. 2020 Jun;1(2):e53-e55
pubmed: 32835328
Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614
pubmed: 32719848
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376
pubmed: 31802125
Clin Microbiol Infect. 2020 Dec;26(12):1706-1708
pubmed: 32659385
Intensive Care Med. 2020 Aug;46(8):1524-1535
pubmed: 32572532
Lancet Respir Med. 2018 Oct;6(10):782-792
pubmed: 30076119

Auteurs

Laura Gouzien (L)

Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, 177, rue de Versailles, 78150 Le Chesnay cedex, France. Electronic address: laura.gouzien@gmail.com.

Theophile Cocherie (T)

Microbiology Laboratory, Centre Hospitalier de Versailles, Le Chesnay, France. Electronic address: tcocherie@gmail.com.

Odile Eloy (O)

Microbiology Laboratory, Centre Hospitalier de Versailles, Le Chesnay, France. Electronic address: oeloy@ch-versailles.fr.

Stéphane Legriel (S)

Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, 177, rue de Versailles, 78150 Le Chesnay cedex, France; Université Paris-Saclay, UVSQ, Inserm, CESP, Team DevPsy, 94807, Villejuif, France. Electronic address: slegriel@ch-versailles.fr.

Jean-Pierre Bedos (JP)

Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, 177, rue de Versailles, 78150 Le Chesnay cedex, France. Electronic address: jpbedos@ch-versailles.fr.

Christelle Simon (C)

Anesthesiology Department, Centre Hospitalier de Versailles, Le Chesnay, France. Electronic address: chsimon@ch-versailles.fr.

Stephanie Marque-Juillet (S)

Microbiology Laboratory, Centre Hospitalier de Versailles, Le Chesnay, France. Electronic address: smarquejuillet@ch-versailles.fr.

Alexis Ferré (A)

Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, 177, rue de Versailles, 78150 Le Chesnay cedex, France. Electronic address: aferre@ch-versailles.fr.

Fabrice Bruneel (F)

Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, 177, rue de Versailles, 78150 Le Chesnay cedex, France. Electronic address: fbruneel@ch-versailles.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH